Immix Biopharma, Inc. <IMMX.O>: H.C. Wainwright raises target price to $25 from $20
IMMX•Related News
Varex Q3 FY26 GAAP EPS returns to profit at $0.37; revenue rises 4% to $211 million
VREX•
Canadian cannabis producer Village Farms beats Q2 sales, EPS estimates on record yields, exports
VFF•
Marex agrees to buy Netherlands-based Brainchild Capital Investments
MRX•
Axsome Q2 FY26 net loss widens to $51.3 million; net product revenue climbs 46% to $218.4 million year over year
AXSM•
Occidental Petroleum Corp <OXY.N>: Truist Securities raises target price to $63 from $57
OXY•